If you take a glucagon-like peptide-1 (GLP-1) agonist for diabetes or weight loss, the American Society of Anesthesiologists (ASA) suggests you stop the medication prior to undergoing surgery or an outpatient procedure in which sedation or general anesthesia will be used, to reduce the risk of aspirating the contents of your stomach. The drug can be safely restarted as prescribed after the procedure.
To continue reading this article or issue you must be a paid subscriber. Sign in
Subscribe to Heart Advisor
Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
